What's new

Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 2, Status: Authorised

May 27, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Ovaleap, follitropin a...

Next Article

Human medicines European public assessment report (EPAR): HyQvia, human normal i...

Related Posts

External guidance on the implementation of the European...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 44, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Arexvy, recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E, Date of authorisation: 06/06/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0